Matthew Ulrickson, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    Miltenyi
    Topic:
    zamtocabtagene
    Date added:
    07/18/2023
    Date updated:
    07/26/2024
    Relationship end date:
    06/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    ADC Therapeutics
    Topic:
    DLBCL
    Date added:
    07/18/2023
    Date updated:
    07/26/2024
    Relationship end date:
    05/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bristol Meyers Squib
    Topic:
    Hematology
    Date added:
    07/18/2023
    Date updated:
    07/26/2024
    Relationship end date:
    03/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genetech
    Topic:
    AML
    Date added:
    07/18/2023
    Date updated:
    07/26/2024
    Relationship end date:
    05/27/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Autolus
    Topic:
    ALL
    Date added:
    07/26/2024
    Date updated:
    07/26/2024
    Relationship end date:
    02/23/2024
Return to Best of Hematology and Breast Cancer 2025, Phoenix